HK1108369A1 - Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof - Google Patents

Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof

Info

Publication number
HK1108369A1
HK1108369A1 HK07113628.6A HK07113628A HK1108369A1 HK 1108369 A1 HK1108369 A1 HK 1108369A1 HK 07113628 A HK07113628 A HK 07113628A HK 1108369 A1 HK1108369 A1 HK 1108369A1
Authority
HK
Hong Kong
Prior art keywords
reverse micelles
acylglycerols
phytosterols
therapeutic use
micelles based
Prior art date
Application number
HK07113628.6A
Other languages
English (en)
Inventor
Jean-Claude Maurel
Original Assignee
Medesis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma Sa filed Critical Medesis Pharma Sa
Publication of HK1108369A1 publication Critical patent/HK1108369A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK07113628.6A 2004-11-02 2007-12-13 Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof HK1108369A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04025991A EP1652513A1 (de) 2004-11-02 2004-11-02 Reverse Mizellen auf der Basis von Sterolen und Acylglycerolen und ihre therapeutischen Verwendungen
PCT/IB2005/003592 WO2006048772A2 (en) 2004-11-02 2005-11-02 Reverse micelles based on phytosterols and acylglycerols and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
HK1108369A1 true HK1108369A1 (en) 2008-05-09

Family

ID=34927201

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113628.6A HK1108369A1 (en) 2004-11-02 2007-12-13 Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof

Country Status (17)

Country Link
US (1) US8637314B2 (de)
EP (2) EP1652513A1 (de)
JP (1) JP4954079B2 (de)
CN (1) CN101102747B (de)
AT (1) ATE503458T1 (de)
AU (1) AU2005300252B2 (de)
CA (1) CA2584980C (de)
DE (1) DE602005027231D1 (de)
DK (1) DK1807046T3 (de)
EA (1) EA012453B1 (de)
ES (1) ES2360809T3 (de)
HK (1) HK1108369A1 (de)
IL (1) IL182747A (de)
PL (1) PL1807046T3 (de)
PT (1) PT1807046E (de)
WO (1) WO2006048772A2 (de)
ZA (1) ZA200704285B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652512A1 (de) * 2004-11-02 2006-05-03 Medesis Pharma Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung
US8877237B2 (en) 2010-03-24 2014-11-04 Medesis Pharma Reverse micelle system comprising nucleic acids and use thereof
WO2011117333A2 (en) * 2010-03-24 2011-09-29 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
CN102940654A (zh) * 2012-10-12 2013-02-27 江苏大学 一种金针菇不皂化提取物甾醇的三元纳米胶束及其制备方法
CN103203192B (zh) * 2013-02-05 2015-08-12 东华大学 一种非离子反胶束体系及其改性极性物质的方法
EP3319588A1 (de) * 2015-07-09 2018-05-16 Medesis Pharma In-situ-herstellung von cyano-verbrückten metallnanopartikeln innerhalb eines biokompatiblen reversmizellaren systems
WO2017031392A1 (en) * 2015-08-20 2017-02-23 University Of Florida Research Foundation, Incorporated Lipid compounds for treatment of obesity, hypertension and metabolic syndrome
CN108822228A (zh) * 2018-06-28 2018-11-16 广东省农业科学院蚕业与农产品加工研究所 一种荔枝多糖的快速纯化方法
WO2023025899A2 (en) * 2021-08-26 2023-03-02 Transgene Delivery system for targeting genes of the interferon pathway

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4038385C2 (de) * 1990-12-01 1998-09-17 Hoyer Gmbh & Co Kg Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
DE19539429C1 (de) * 1995-10-24 1997-04-24 Kawes S L Wasser/Öl-Misch-Emulgator sowie dessen Verwendung in kosmetischen und pharmazeutischen Salben, Cremes, Lotionen, Seifen, Shampoos und Badezusätzen
US5693516A (en) * 1995-11-27 1997-12-02 Novo Nordisk Biotech, Inc. Method for solubilizing proteins in organic solvents
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
JP2003507874A (ja) * 1999-08-26 2003-02-25 ユニバーシティ オブ ニュー ハンプシャー 多段型の質量分析計
US6951655B2 (en) * 2001-10-11 2005-10-04 Imi Biomed, Inc. Pro-micelle pharmaceutical compositions
JP5100974B2 (ja) * 2004-04-28 2012-12-19 花王株式会社 油脂組成物
EP1652512A1 (de) * 2004-11-02 2006-05-03 Medesis Pharma Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung

Also Published As

Publication number Publication date
CA2584980A1 (en) 2006-05-11
PT1807046E (pt) 2011-05-06
PL1807046T3 (pl) 2011-09-30
DE602005027231D1 (de) 2011-05-12
AU2005300252B2 (en) 2010-08-26
ES2360809T3 (es) 2011-06-09
EP1807046B1 (de) 2011-03-30
JP4954079B2 (ja) 2012-06-13
US20090087406A1 (en) 2009-04-02
ATE503458T1 (de) 2011-04-15
DK1807046T3 (da) 2011-05-23
EA012453B1 (ru) 2009-10-30
JP2008519025A (ja) 2008-06-05
WO2006048772A2 (en) 2006-05-11
EA200700993A1 (ru) 2007-10-26
WO2006048772A3 (en) 2006-10-19
EP1652513A1 (de) 2006-05-03
CN101102747A (zh) 2008-01-09
EP1807046A2 (de) 2007-07-18
CA2584980C (en) 2014-01-07
IL182747A0 (en) 2007-07-24
IL182747A (en) 2011-12-29
US8637314B2 (en) 2014-01-28
CN101102747B (zh) 2012-10-24
AU2005300252A1 (en) 2006-05-11
ZA200704285B (en) 2009-04-29

Similar Documents

Publication Publication Date Title
HK1108369A1 (en) Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof
CA3094580C (en) Oral formulations of cytidine analogs and methods of use thereof
WO2008021088A3 (en) Salicylanilides enhance oral delivery of therapeutic peptides
EP2322146A3 (de) Mikrokapselformulierung mit zwei pharmazeutischen Wirkstoffen
WO2006004449A3 (en) A combination composition
MXPA05002814A (es) Formulacion para agentes lipofilicos.
WO2004006858A3 (en) Compounds, compositions, and methods employing same
IL178822A (en) Amide @@ - @Phenylamino-Quinzoline-6-YL, medicinal preparations containing them, and their use in the preparation of drugs for the treatment of proliferative disorders
WO2005112633A3 (en) Compounds and compositions for delivering active agents
WO2003092580A3 (en) Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
IL151503A0 (en) Therapeutic combinations of antihypertensive and antiagiogenic agents
PT1317419E (pt) Compostos e composições de ácido cianofenoxicarboxílico para administrar agentes activos
WO2007025005A3 (en) Sustained release formulations of nalbuphine
SG159559A1 (en) Pharmaceutical product
WO2007035783A3 (en) Combination formulations of cytidine analogs and platinum agents
WO2004066983A3 (en) Controlled release of highly soluble agents
WO2006064228A3 (en) Thiazolopyramidine compounds for the modulation of chemokine receptor activity
AU2003231260A1 (en) Catechin multimers as therapeutic drug delivery agents
WO2006117404A3 (de) Topische verwendung von radikalfangenden substanzen zur antipyretischen behandlung
WO2005056520A8 (en) Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
EP1273301A3 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung bieten
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
WO2006124556A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
AU2003224808A1 (en) Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
PL371518A1 (en) Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181102